AbbVie (NY:ABBV)
263.95
-1.17
(-0.44%)
Streaming Delayed Price
Updated: 1:14 PM EDT, Sep 25, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 777,388 |
| Open | 265.49 |
| Bid (Size) | 263.91 (100) |
| Ask (Size) | 263.99 (100) |
| Prev. Close | 265.12 |
| Today's Range | 262.59 - 266.00 |
| 52wk Range | 190.75 - 269.39 |
| Shares Outstanding | N/A |
| Dividend Yield | 2.62% |
Top News
More News
AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026? ↗
September 24, 2026
Via The Motley Fool
Topics
Intellectual Property
Performance
| YTD |
+15.1%
|
+15.1%
|
| 1 Month |
-0.7%
|
-0.7%
|
| 3 Month |
+8.6%
|
+8.6%
|
| 6 Month |
+25.0%
|
+25.0%
|
| 1 Year |
+20.0%
|
+20.0%
|
More News
Read More
AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September? ↗
September 22, 2026
Via The Motley Fool
Reflecting On Therapeutics Stocks’ Q2 Earnings: AbbVie (NYSE:ABBV)
September 21, 2026
Via StockStory
Topics
Artificial Intelligence
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? ↗
September 18, 2026
Via The Motley Fool
Topics
Intellectual Property
Via The Motley Fool
Topics
Economy
Is AbbVie the Best Dividend King to Buy in September? ↗
September 16, 2026
Via The Motley Fool
Topics
Intellectual Property
3 Dividend Stocks That Are No-Brainer Buys Right Now, Starting With This Healthcare Giant ↗
September 15, 2026
Via The Motley Fool
Topics
Intellectual Property
AbbVie Maps Post-HUMIRA Growth With Apogee Deal, Immunology Pipeline ↗
September 15, 2026
Via MarketBeat
Topics
ETFs
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗
September 14, 2026
Via The Motley Fool
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026? ↗
September 10, 2026
Via The Motley Fool
Topics
Intellectual Property
Via Benzinga
2 Dividend Stocks Built to Hold Up When Markets Don't ↗
September 09, 2026
Via The Motley Fool
Move Aside, Pfizer: This Stock Is the Smarter Dividend Buy Right Now ↗
September 08, 2026
Via The Motley Fool
Topics
Intellectual Property
Via MarketBeat
3 Dividend Stocks to Buy and Hold Forever (Including 1 Dividend King) ↗
September 05, 2026
Via The Motley Fool
Topics
Intellectual Property
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? ↗
September 04, 2026
Via The Motley Fool
Topics
Intellectual Property
True Beauty Aesthetics Marks One-Year Milestone With Open House
September 02, 2026
Via Press Advantage
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 263.95
When was AbbVie last traded?
The last trade of AbbVie was at 09/25/26 01:14 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>